Corcept Therapeutics (CORT) PT Lowered to $28 at Truist Securities

November 8, 2022 8:05 AM EST
Get Alerts CORT Hot Sheet
Price: $23.40 +2.36%

Rating Summary:
    9 Buy, 6 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 27 | New: 11
Join SI Premium – FREE
Truist Securities analyst Gregory Fraser lowered the price target on Corcept Therapeutics (NASDAQ: CORT) to $28.00 (from $30.00) while maintaining a Hold rating.

You May Also Be Interested In

Related Categories

Analyst PT Change